Issued Patents 1997
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 5695994 | Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules | Pierre van der Bruggen, Etienne De Plaen, Christophe Lurguin, Catia Traversari, Beatrice Gaugler +1 more | 1997-12-09 |
| 5686068 | Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof | Cornelius Melief, M. W. Visseren, Sjoerd Henricus Van Der Burg, Pierre van der Bruggen | 1997-11-11 |
| 5683886 | Tumor rejection antigens which correspond to amino acid sequences in tumor rejection antigen precursor bage, and uses thereof | Pierre van der Bruggen | 1997-11-04 |
| 5648226 | Isolated peptides derived from tumor rejection antigens, and their use | Benoit Van den Eynde, Olivier DeBacker | 1997-07-15 |
| 5629166 | Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of HLA-C-clone 10/MAGE-1 derived peptides, and methods for treating said individuals | Pierre van der Bruggen | 1997-05-13 |
| 5620886 | Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 | Vincent Brichard, Aline Van Pel, Catia Traversari, Thomas W olfel, Etienne De Plaen | 1997-04-15 |
| 5612201 | Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor | Etienne De Plaen, Bernard Lethe, Jean-Pierre Szikora, Charles De Smet, Patrick Chomez | 1997-03-18 |
| 5610013 | Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors | Benoit Van den Eynde | 1997-03-11 |
| 5591430 | Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof | Alan Townsend, Judy Bastin, Pierre van der Bruggen, Pierre Coulie, Thomas F. Gajewski | 1997-01-07 |